IRD
Opus Genetics, Inc.
5.10$
+6.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 0.7% | 0.0% | 0.0% | 0.1% | 0.4% | |
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 2,576.1% | 36.0% | 92.7% | 244.3% | 217.0% | |
| – | – | 1,378.8% | 18.2% | 62.8% | 165.7% | 154.9% | |
| – | – | 3,954.8% | 54.3% | 155.5% | 664.7% | 371.9% | |
| – | – | -3,854.8% | 45.7% | -55.5% | -564.7% | -271.9% | |
| – | – | 0.3% | 0.0% | 7.0% | 0.0% | 10.3% | |
| – | – | -9,625.3% | 45.7% | -52.4% | -523.4% | -349.3% | |
| – | – | – | 0.8% | 0.1% | – | – | |
| – | – | -9,625.3% | 44.9% | -52.4% | -523.4% | -349.3% | |
| – | – | -9,624.3% | 45.7% | -52.3% | -523.3% | -338.6% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.